Effects of 5′-Alkyl-Benzothiadiazides on (R,S)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Biophysics and Synaptic Responses
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 62 (3) , 566-577
- https://doi.org/10.1124/mol.62.3.566
Abstract
Alkyl-substituted benzothiadiazides (BTDs) were tested for their effects on (R,S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors. In excised patches, the 5′-ethyl derivative “D1” blocked the desensitization of AMPA receptor currents during prolonged application of glutamate (EC50, 36 μM), and it slowed deactivation of responses elicited by 1-ms glutamate pulses greater than 10-fold. [3H]Fluorowillardiine binding to rat synaptic membranes was increased by D1 by a factor of 3.6 (EC50, 17 μM) with a Hill coefficient near 2. In hippocampal slices, the compound reversibly increased excitatory postsynaptic currents and field excitatory postsynaptic potentials (EPSPs) with thresholds around 10 μM. The size of the alkyl substituent influenced both the potency and nature of the drug effect on synaptic currents: 5′-methyl compounds had a 2-fold greater effect on response amplitude than on response duration, whereas 5′-ethyl compounds like D1 caused greater increases in duration than amplitude. In tests with recombinantly expressed AMPA receptor subunits, D1 preferred the glutamate receptor (GluR) subunit GluR4 flip (0.64 μM) over GluR4 flop (5.3 μM); similar affinities but with smaller flip-flop differences were obtained for GluR1 through 3. These results show that D1 and congeners are significantly more potent than the parent compound IDRA-21 and that they differ in two fundamental aspects from cyclothiazide, the most widely studied BTD: 1) D1 markedly increases the agonist affinity of AMPA receptors and 2) it has immediate and large effects on field EPSPs. The large gain in potency conferred by alkyl substitution suggests that the 5′ substituent is in intimate contact with the receptor, with the size of the substituent determining the way in which receptor kinetics is changed.Keywords
This publication has 49 references indexed in Scilit:
- The Diazoxide Derivative 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-S,S-dioxide Augments AMPA- and GABA-Mediated Synaptic Responses in Cultured Hippocampal NeuronsNeurobiology of Disease, 1998
- 4H-1,2,4-Pyridothiadiazine 1,1-Dioxides and 2,3-Dihydro-4H-1,2,4-pyridothiadiazine 1,1-Dioxides Chemically Related to Diazoxide and Cyclothiazide as Powerful Positive Allosteric Modulators of (R/S)-2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors: Design, Synthesis, Pharmacology, and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1998
- Enantioselective synthesis of a pyrrolo-benzothiadiazine derivative S 18986, a new AMPA receptor positive modulatorBioorganic & Medicinal Chemistry Letters, 1996
- Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in ratsBrain Research, 1996
- Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slicesNeuroReport, 1996
- Differential diagnosis in acute psychotic episodeInternational Clinical Psychopharmacology, 1996
- Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neuronsNeuron, 1995
- Effects of cyclothiazide on synaptic responses in slices of adult and neonatal rat hippocampusNeuroReport, 1994
- A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning‐dependent taskSynapse, 1993
- A benzodiazepine recognition site associated with the non-NMDA glutamate receptorNeuron, 1993